Medterra CBD is moving beyond CBD isolate with its latest product line. Medterra Broad Spectrum Tinctures are bringing whole-hemp formulas to the Irvine, Calif.-based company’s shoppers while upholding its no-THC standard. 

"At Medterra, we strive to provide everyone with the highest-quality CBD products on the market and could not be more excited to introduce our line of Broad Spectrum Tinctures," said Medterra CEO Jay Hartenbach. "With growing consumer demand for different cannabinoids, we're excited to offer them exactly that, but without the effects of THC."

The broad-spectrum offerings will be available in 1,000- and 2,000-mg strengths — the former of which retails for $59.99 and the latter of which is priced at $99.99. The products are available in three varieties — unflavored, strawberry mint flavor and citrus flavor. 

Among the cannabinoids present in the tinctures are cannabinol, or CBN, and cannabigerol, or CBG. Each bottle contains 30 servings. 

Currently, Medterra said it is the most widely distributed CBD company in the world, with its products available through grocery, drug and online retailers at more than 18,000 retail locations.